ALNY
Alnylam Pharmaceuticals Inc.
Latest News for ALNY
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Alnylam Pharma, with a price target of $570.00. The co......
In a report released on October 30, Luca Issi from RBC Capital maintained a Buy rating on Alnylam Pharma, with a price target of $500.00. The compa......
Alnylam Pharmaceuticals (($ALNY)) announced an update on their ongoing clinical study. Alnylam Pharmaceuticals has announced a new clinical study t......
Evercore ISI analyst Cory Kasimov maintained a Buy rating on Alnylam Pharma today and set a price target of $515.00. The company’s shares opened to......
Barclays analyst Gena Wang maintained a Buy rating on Alnylam Pharma today and set a price target of $527.00. The company’s shares closed yesterday......
Alnylam Pharmaceuticals (($ALNY)) announced an update on their ongoing clinical study. Alnylam Pharmaceuticals is conducting a pivotal Phase 3 clin......
In a report released today, William Pickering from Bernstein maintained a Buy rating on Alnylam Pharma, with a price target of $471.00. The company......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $436.38 | -2.1% | 1.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW